We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANN
651
DELISTED
ANN INC
ANN
| $577K | 0.01% |
14,017
+4,026
| +40% | +$161K |
|
652
Olin
OLN
$1.94B
| $576K | 0.01% |
21,414
+13,949
| +187% | +$386K |
|
653
SL Green Realty
SLG
$3.67B
| $576K | 0.01% |
+5,435
| New | +$562K |
|
654
Vishay Intertechnology
VSH
$4.8B
| $576K | 0.01% |
37,154
+18,547
| +100% | +$275K |
|
655
Aflac
AFL
$58.6B
| $574K | 0.01% |
18,436
-23,958
| -57% | -$747K |
|
|
SPN
656
DELISTED
Superior Energy Services, Inc.
SPN
| $572K | 0.01% |
1,583
-13,005
| -89% | -$4.31M |
|
657
First Solar
FSLR
$20.5B
| $571K | 0.01% |
8,029
-56,368
| -88% | -$3.73M |
|
|
EGN
658
DELISTED
Energen
EGN
| $566K | 0.01% |
6,373
-3,971
| -38% | -$334K |
|
659
Camden Property Trust
CPT
$11.7B
| $563K | 0.01% |
7,906
+4,895
| +163% | +$340K |
|
660
SEI Investments
SEIC
$12.6B
| $559K | 0.01% |
+17,069
| New | +$550K |
|
661
Cathay General Bancorp
CATY
$4.14B
| $558K | 0.01% |
+21,849
| New | +$538K |
|
662
MSC Industrial Direct
MSM
$6.73B
| $555K | 0.01% |
+5,805
| New | +$527K |
|
|
CLD
663
DELISTED
Cloud Peak Energy Inc
CLD
| $555K | 0.01% |
+30,144
| New | +$592K |
|
664
T. Rowe Price
TROW
$21.8B
| $553K | 0.01% |
+6,550
| New | +$534K |
|
665
PepsiCo
PEP
$183B
| $551K | 0.01% |
+6,162
| New | +$532K |
|
|
TIF
666
DELISTED
Tiffany & Co.
TIF
| $551K | 0.01% |
+5,499
| New | +$510K |
|
667
Invesco
IVZ
$13.3B
| $550K | 0.01% |
14,560
-35,986
| -71% | -$1.3M |
|
668
Teradata
TDC
$2.71B
| $547K | 0.01% |
13,612
+3,912
| +40% | +$171K |
|
|
GAP
669
The Gap Inc
GAP
$7.09B
| $547K | 0.01% |
13,170
-38,017
| -74% | -$1.54M |
|
670
Church & Dwight Co
CHD
$22.7B
| $545K | 0.01% |
15,582
+8,154
| +110% | +$280K |
|
671
Duke Energy
DUK
$91.8B
| $545K | 0.01% |
7,346
-5,288
| -42% | -$380K |
|
672
ArcelorMittal
MT
$55.1B
| $545K | 0.01% |
+15,963
| New | +$574K |
|
673
Bank OZK
OZK
$5.23B
| $544K | 0.01% |
+16,278
| New | +$505K |
|
674
Starwood Property Trust
STWD
$5.55B
| $544K | 0.01% |
+22,880
| New | +$545K |
|
675
Edwards Lifesciences
EW
$51.5B
| $543K | 0.01% |
37,956
-2,364
| -6% | -$32K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.